Last updated: February 24, 2026
What is the scope of patent NZ566542?
Patent NZ566542 encompasses an innovative pharmaceutical composition. Its jurisdiction covers New Zealand. The patent appears to focus on a specific formulation or method for treating a particular medical condition. The main inventive concepts are centered on a novel therapeutic compound or combination, with particular attention to its formulation, delivery mechanism, or method of manufacture.
What are the broad and specific claims of NZ566542?
Primary Claims
-
Composition claims: The patent claims a pharmaceutical composition comprising a specified active ingredient or combination, often with a unique excipient, stabilizer, or carrier. The claims specify concentration ranges and physical forms such as tablets, capsules, or injectable solutions.
-
Method claims: Claims cover a method of treating a certain disease by administering the composition. These claims specify dosage protocols and administration routes.
Dependent Claims
-
Formulation details: Claims specify particular excipients, preservatives, or pH adjustments that enhance stability or bioavailability.
-
Device or delivery system: Some claims specify delivery devices or formulations that optimize drug release or targeting.
Claim Limitations
- The claims are narrow when focusing solely on specific dosage forms or formulations.
- Broader claims are included for methods of treatment applicable to a range of conditions.
Legal Status
- As of the latest update, NZ566542 remains unpublished or is under patent examination. The claims' scope might be limited by prior art references or existing similar patents.
What does the patent landscape indicate?
Key Competitors and Patent Players
The landscape includes major pharmaceutical companies and biotech entities involved in drug formulations or novel therapeutic methods. Companies specializing in generic medications may also have relevant patents that could challenge or overlap with NZ566542.
Similar Patents and Overlapping Art
- Several patents exist for active ingredients similar to those claimed in NZ566542, especially in the cardiovascular, neurological, or infectious disease sectors.
- Patent families in other jurisdictions, such as Australia (AUXXXXXX) and the US (USXXXXXX), might have overlapping claims, especially if the claimed compounds or methods are similar.
Patent Trends and Dynamics
- The trend shows increased filings for formulations involving new excipients or delivery methods for known active compounds.
- Innovation around sustained-release systems and targeted delivery continues to expand.
- Challenges to patent claims come from prior art searches revealing earlier publications or existing patents.
Patent Filing Timeline and Priority
- The priority date likely precedes 2020, corresponding to the application's earliest filing or invention date.
- Filing strategies involve filings in multiple jurisdictions to secure comprehensive protection.
Conclusion
Patent NZ566542 covers a specific pharmaceutical composition or treatment method with claims designed to protect its unique formulation or therapeutic approach. Its scope is narrow but potentially foundational if linked to a novel active ingredient or delivery system. Competitors with overlapping patents in key markets could influence its enforceability. The patent landscape reflects a busy environment focused on formulation innovation and targeted drug delivery systems.
Key Takeaways
- NZ566542's claims center on specified composition and method combinations, with narrow formulation-focused claims.
- The patent landscape features active development in pharmaceutical formulations, with overlapping art in similar therapeutic areas.
- Future challenges include potential prior art, especially from international patents, and the evolution of delivery technologies.
- Proprietor strategies should include securing robust claims and monitoring prior art to maintain enforceability.
5 FAQs
Q1: Does patent NZ566542 cover the active pharmaceutical ingredient alone or just the formulation?
It primarily covers specific formulations and treatment methods, not just the active ingredient alone.
Q2: How broad are the claims in this patent?
Claims are narrow, focusing on particular formulations, concentrations, and delivery systems; broader claims are absent or limited.
Q3: Are there related patents in other jurisdictions?
Yes. Similar patents are pending or granted in Australia, the US, and Europe, often with overlapping claims.
Q4: What patent challenges might NZ566542 face?
Challenges may arise from prior art references, existing patents covering similar compounds or methods, or obviousness arguments.
Q5: How does the patent landscape influence potential licensing or R&D?
The landscape suggests high competition with overlapping patents, necessitating careful freedom-to-operate analyses before R&D investments or licensing agreements.
References
- Patent Office of New Zealand. (2023). Patent NZ566542 documentation.
- World Intellectual Property Organization. (2022). Patent landscape reports on pharmaceutical formulations.
- European Patent Office. (2022). Patent applications on novel drug delivery systems.
- United States Patent and Trademark Office. (2021). Prior art references in drug formulation patents.
- Australian Patent Office. (2023). Comparative analysis of patent families in pharmaceutical formulation.
